Percutaneous coronary intervention (PCI) with bioabsorb-able stents has created interest
because the need for mechanical support for the healing artery is temporary, and beyond …

Background Drug-eluting metallic coronary stents predispose to late stent thrombosis,
prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair …

Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall
when needed and then disappears once the acute recoil and constrictive remodelling …

Using wide-angle, phased-array, two-dimensional echocardiography, mitral leaflets and
their annular attachments were recorded from a view close to the standard apical four …

In a double-blind trial of streptokinase for acute myocardial infarction, 219 consecutive
patients presenting with infarction within four hours (mean, 3.0±0.8) of the onset of chest …

Objectives: The aim of this study was to demonstrate that the prevention of early scaffold
area shrinkage of the ABSORB BVS (Rev. 1.1, Abbott Vascular, Santa Clara, California) was …

Background—The first generation of the bioresorbable everolimus drug-eluting vascular
scaffold showed signs of shrinkage at 6 months, which largely contributed to late luminal …

The tricuspid valve leaflets and their annular attachments were recorded by two-dimensional
echocardiography from a view of the right ventricular inflow tract obtained by placing the …

Aims To assess observations with multimodality imaging of the Absorb bioresorbable
everolimus-eluting vascular scaffold performed in two consecutive cohorts of patients who …

Objectives: This study sought to demonstrate the 5-year clinical and functional multislice
computed tomography angiographic results after implantation of the fully resorbable …